Lubiprostone Market
Lubiprostone Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Lubiprostone Market Size and Growth
The Lubiprostone market is experiencing steady growth, driven by increasing incidence of gastrointestinal disorders and rising demand for effective treatments. The global market size was valued at approximately $1.2 billion in 2022, with expectations to reach $1.6 billion by 2027, reflecting a compound annual growth rate of around 6%.
Companies Covered (Covid 19 Impact Covered)
The Lubiprostone market is competitive, with key players like Takeda Pharmaceuticals leading. Takeda promotes Lubiprostone for chronic constipation and IBS management, expanding its usage and driving market growth. Sales revenues include:
- Takeda: ~$16 billion (2022)
- Other players: Vary significantly, enhancing market dynamics through innovation and partnerships.
Request Sample Report
Takeda Pharmaceuticals
Market Segmentation
By Application
CIC and OIC
IBS-C
Request Sample Report
By Product
8 mcg Capsules
24 mcg Capsules
$ 233.54 Billion
Request Sample Report
